1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Psaila B and Lyden D: The metastatic
niche: adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Weigelt B, Peterse JL and van’t Veer LJ:
Breast cancer metastasis: markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
5
|
Liotta LA: Tumor invasion and metastases:
role of the basement membrane. Warner-Lambert Parke-Davis Award
lecture. Am J Pathol. 117:339–348. 1984.PubMed/NCBI
|
6
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
7
|
Nagase H and Woessner JF Jr: Matrix
metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI
|
8
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Nuti E, Tuccinardi T and Rossello A:
Matrix metalloproteinase inhibitors: new challenges in the era of
post broad-spectrum inhibitors. Curr Pharm Des. 13:2087–2100. 2007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Gao R, Zhu BH, Tang SB, Wang JF and Ren J:
Scutellarein inhibits hypoxia- and moderately-high glucose-induced
proliferation and VEGF expression in human retinal endothelial
cells. Acta Pharmacol Sin. 29:707–712. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li NG, Song SL, Shen MZ, Tang YP, Shi ZH,
Tang H, Shi QP, Fu YF and Duan JA: Mannich bases of scutellarein as
thrombin-inhibitors: design, synthesis, biological activity and
solubility. Bioorgan Med Chem. 20:6919–6923. 2012. View Article : Google Scholar
|
14
|
Goh D, Lee YH and Ong ES: Inhibitory
effects of a chemically standardized extract from Scutellaria
barbata in human colon cancer cell lines, LoVo. J Agr Food Chem.
53:8197–8204. 2005. View Article : Google Scholar
|
15
|
Chen G, Shi X, Sun C, Li M, Zhou Q, Zhang
C, Huang J, Qiu Y, Wen X, Zhang Y, et al: VEGF-mediated
proliferation of human adipose tissue-derived stem cells. PloS One.
8:e736732013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Helbig G, Christopherson KW 2nd,
Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE and
Nakshatri H: NF-kappaB promotes breast cancer cell migration and
metastasis by inducing the expression of the chemokine receptor
CXCR4. J Biol Chem. 278:21631–21638. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Luo JL, Kamata H and Karin M:
IKK/NF-kappaB signaling: balancing life and death - a new approach
to cancer therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Harvey AL: Natural products in drug
discovery. Drug Discov Today. 13:894–901. 2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Koehn FE and Carter GT: The evolving role
of natural products in drug discovery. Nat Rev Drug Discov.
4:206–220. 2005. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Pan ZW, Feng TM, Shan LC, Cai BZ, Chu WF,
Niu HL, Lu YJ and Yang BF: Scutellarin-induced
endothelium-independent relaxation in rat aorta. Phytother Res.
22:1428–1433. 2008. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Chan JY, Tan BK and Lee SC: Scutellarin
sensitizes drug-evoked colon cancer cell apoptosis through enhanced
caspase-6 activation. Anticancer Res. 29:3043–3047. 2009.PubMed/NCBI
|
22
|
Li H, Huang D, Gao Z, Lv Y, Zhang L, Cui H
and Zheng J: Scutellarin inhibits cell migration by regulating
production of αvβ6 integrin and E-cadherin in human tongue cancer
cells. Oncol Rep. 24:1153–1160. 2010.PubMed/NCBI
|
23
|
Qian LH, Li NG, Tang YP, Zhang L, Tang H,
Wang ZJ, Liu L, Song SL, Guo JM and Ding AW: Synthesis and
bio-activity evaluation of scutellarein as a potent agent for the
therapy of ischemic cerebrovascular disease. Int J Mol Sci.
12:8208–8216. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Muller A, Homey B, Soto H, Ge NF, Catron
D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001. View
Article : Google Scholar : PubMed/NCBI
|
26
|
Fidler IJ: Timeline - the pathogenesis of
cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat
Rev Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Eccles SA and Welch DR: Metastasis: recent
discoveries and novel treatment strategies. Lancet. 369:1742–1757.
2007. View Article : Google Scholar : PubMed/NCBI
|
28
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
29
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer: trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
31
|
Perkins ND: The diverse and complex roles
of NF-κB subunits in cancer. Nat Rev Cancer. 12:121–132.
2012.PubMed/NCBI
|
32
|
Orlowski RZ and Baldwin AS: NF-κB as a
therapeutic target in cancer. Trends Mol Med. 8:385–389. 2002.
View Article : Google Scholar : PubMed/NCBI
|